Groundbreaking medical achievement unfolds as surgeons successfully perform world’s first pig-to-human liver transplant. The recipient, a 71-year-old man, suffered from irreversible scarring caused by hepatitis B infection and liver cancer, rendering his liver beyond repair.
The innovative procedure involved transplanting a genetically modified pig liver into the patient, providing a vital lifeline. Doctors at the First Affiliated Hospital of Anhui Medical University in China expertly performed the surgery, marking a significant milestone in xenotransplantation.
This pioneering surgery showcases the potential of genetically engineered pig livers to support key metabolic and synthetic functions in humans.
Although the patient ultimately passed away 171 days post-transplant due to complications, the procedure demonstrates promise for treating patients with acute liver failure or hepatocellular carcinoma.
As the medical community continues to push boundaries, this achievement sparks hope for addressing the global organ shortage.
Thousands of patients die annually awaiting transplants, and breakthroughs like this bring us closer to finding alternative solutions. With further research and refinement, xenotransplantation may revolutionize the field of organ transplantation, offering new possibilities for patients in need.
